Pharmaceutical Executive Digest:
Having trouble viewing this e-mail? Click here.
Share with a colleague
Pharmaceutical Executive Europe  E-News
 
 
 
 
 

You can now follow us on Twitter at Twitter.com/pharmexecutive
 
Survey
We asked 40 pharma professionals, Where do you think your company should be investing to increase profitability?
New regions 17%
New therapeutic areas 33%
New technology 8%
Outsourcing 10%
Sales & marketing 8%
In-house expertise 24%

Talk to us:
jupton@advanstar.com

Advertise with us:
wblow@advanstar.com

17 December, 2013
Industry Optimism Outweighs Job Security: Pharm Tech’s Employment Survey 2013
Amid the environment of a gradual economic recovery and continued consolidation of biopharma companies, respondees to the Pharmaceutical Technology 2013 employment survey expressed muted optimism despite stagnant employment options ...Read more
2014: The Year of Digital Pharma?
2014 might be the year that pharma finally has to get really serious about digital, at least if analysts at Forrester Research are right. Peter Houston reports ... Read more
Biotechnology Innovation and Growth in Israel
Israel’s diverse population, high-quality healthcare system, and resilience to global financial stress make it a strong partner for R&D, clinical research, and market growth, writes Jill E. Sackman and Michael Kuchenreuther ... Read more
EMA and EUnetHTA Agree Three-Year Work Plan
Collaboration seems to be ‘in’ thing and it’s set to continue in Europe with the European Medicines Agency (EMA) and EUnetHTA agreeing a three-year joint work plan. Leela Barham reports ... Read more
Product Profile
Sciformix
Product labeling– Increasing efficiency, enhancing quality, and delivering compliance
Pharmaceutical product labeling is a highly regulated and complex process. A product label is very specific in its content, with respect to safety data, adverse effects and compliance to country specific regulations. Read More.
Also in this issue
Pharm Exec Round Table on Market Access
GSK Invests in UK Manufacturing
Pharm Exec Global Digest: Personalized Medicine Special